The SARS-CoV-2 vaccine could be launched in European Union countries in the first quarter of next year, says Andrea Ammon, head of the European Center for Disease Prevention and Control (ECDC), Euronews reported.
The European Union could pay $ 10 billion to deliver hundreds of millions of doses of vaccines developed by Pfizer / BioNTech and CureVac, according to Mediafax.
The American company Modern announced this week that it is 94.5% effective for the anti-COVID-19 vaccine, which is developing, making it the second company to offer results in the US far beyond expectations.
The European Medicines Agency (EMA) is currently “in ongoing discussions with the FDA (Food and Drug Administration) to synchronize evaluations of coronavirus vaccines,” said European Commission President Ursula von der Leyen.
To date, the EU has signed five pre-contract contracts with AstraZeneca, Johnson & Johnson, CureVac, Pfizer / BioNTech and Santofi-GSK.